Our analysis also showed that higher levels of OCT-4 and NANOG expression were associated with worse survival of RCC patients, indicating these stem cell pluripotency factors might be a common pathway for inhibition of CSCs. This evidence concerns the gene POU5F1 and renal cell carcinoma.